Kidney damage by COVID-19 and rationale for extracorporeal therapies. Biomedical Research and Therapy, [S. l.], v. 7, n. 10, p. 4071–4074, 2020. DOI: 10.15419/bmrat.v7i10.644. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/644.. Acesso em: 8 apr. 2025.